Advancing Care for HER: Lessons from Real-World Data to Improve HER2+ Early Stage Breast Cancer Treatment

Advancing Care for HER: Lessons from Real-World Data to Improve HER2+ Early Stage Breast Cancer Treatment is organized by Prime Education, LLC.

Intended Audience:
Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, Nurses, and Case Managers.

Release Date: July 26, 2019
Expiration Date: July 26, 2020

Accreditation:
• 1.0 CE for Physicians (AMA Category 1)
• 1.0 CE for Physician Assistants
• 1.0 CE for Nurse Practitioners
• 1.0 CE for Pharmacists (Automatic NABP)
• 1.0 CE for Nurses
• 1.0 CE for Case Managers (CCMC)

Course Description:
Early-stage HER2+ breast cancer patient outcomes have drastically improved through the use of HER2-targeted agents. However, a recently concluded quality improvement initiative completed by PRIME highlighted challenges that still remain, including care coordination and shared decision-making. In this webcast, two leading breast cancer oncology experts discuss real-world insights to address challenges in early-stage HER2+ breast cancer treatment, emerging clinical trial data for targeted agents, and guidelines for neoadjuvant and adjuvant treatment.

Learning Objectives:
• Assess common areas for improvement in guideline-directed, coordinated, and patient-centered aspects of early-stage HER2+ breast cancer
• Evaluate the latest clinical trial data for treatment options in the adjuvant and neoadjuvant setting
• Apply strategies for timely, effective, and safe utility of existing and novel targeted therapies in the early-stage setting
• Develop and implement systems- and team-based action plans to improve care coordination, interprofessional collaborative practice, and shared decision-making for patients with early-stage HER2+ breast cancer

Additional details will be posted as soon as information is available.